HK1219722A1 - -磺酰基派啶衍生物作為前動力蛋白受體的調節劑 - Google Patents
-磺酰基派啶衍生物作為前動力蛋白受體的調節劑Info
- Publication number
- HK1219722A1 HK1219722A1 HK16107004.1A HK16107004A HK1219722A1 HK 1219722 A1 HK1219722 A1 HK 1219722A1 HK 16107004 A HK16107004 A HK 16107004A HK 1219722 A1 HK1219722 A1 HK 1219722A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- modulators
- piperidine derivatives
- prokineticin receptors
- sulfonyl
- sulfonyl piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201311169A GB201311169D0 (en) | 2013-06-21 | 2013-06-21 | Therapeutic compounds |
| GB201314397A GB201314397D0 (en) | 2013-08-09 | 2013-08-09 | Therapeutic Compounds |
| PCT/GB2014/051900 WO2014202999A1 (en) | 2013-06-21 | 2014-06-20 | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1219722A1 true HK1219722A1 (zh) | 2017-04-13 |
Family
ID=50982934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16107004.1A HK1219722A1 (zh) | 2013-06-21 | 2016-06-17 | -磺酰基派啶衍生物作為前動力蛋白受體的調節劑 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10208016B2 (zh) |
| EP (1) | EP3010900B1 (zh) |
| JP (1) | JP6401254B2 (zh) |
| CN (1) | CN105324372B (zh) |
| AU (1) | AU2014282977B2 (zh) |
| CA (1) | CA2914263C (zh) |
| EA (1) | EA029430B1 (zh) |
| HK (1) | HK1219722A1 (zh) |
| WO (1) | WO2014202999A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201420095D0 (en) * | 2014-11-12 | 2014-12-24 | Takeda Pharmaceutical | New use |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996006098A1 (en) | 1994-08-24 | 1996-02-29 | Astra Aktiebolag | Spiro-azabicyclic compounds useful in therapy |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
| SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| SE9903760D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
| SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
| SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| SE0002729D0 (sv) | 2000-07-20 | 2000-07-20 | Astrazeneca Ab | Novel compound form |
| NZ539828A (en) | 2001-05-18 | 2007-01-26 | Astrazeneca Ab | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| MXPA03010996A (es) | 2001-06-01 | 2004-02-27 | Aztrazeneca Ab | Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia. |
| EP1676844A1 (en) * | 2004-12-28 | 2006-07-05 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
| MXPA04010193A (es) | 2002-04-18 | 2005-02-03 | Astrazeneca Ab | Compuesto de tienilo. |
| JP4511195B2 (ja) | 2002-04-18 | 2010-07-28 | アストラゼネカ・アクチエボラーグ | フリル化合物 |
| ES2326638T3 (es) | 2002-04-18 | 2009-10-16 | Astrazeneca Ab | Compuestos heterociclicos. |
| SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
| SE0202430D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
| SE0202598D0 (sv) | 2002-09-02 | 2002-09-02 | Astrazeneca Ab | Alpha-7 Nicotinic receptor agonists and statins in combination |
| JP2006506451A (ja) * | 2002-10-11 | 2006-02-23 | アストラゼネカ アクチボラグ | １，４−ジ置換ピペリジン誘導体および１１−βＨＳＤ１阻害薬としてのそれらの使用 |
| PL1699455T3 (pl) * | 2003-12-15 | 2013-10-31 | Merck Sharp & Dohme | Heterocykliczne inhibitory proteaz aspartylowych |
| BRPI0515500A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
| JP2009518409A (ja) | 2005-12-06 | 2009-05-07 | メルク エンド カムパニー インコーポレーテッド | モルホリンカルボキサミドプロキネチシン受容体アンタゴニスト |
| EP1976528A2 (en) | 2005-12-29 | 2008-10-08 | Janssen Pharmaceutica, N.V. | Prokineticin 2 receptor antagonists |
| WO2010077976A2 (en) * | 2008-12-17 | 2010-07-08 | The Regents Of The University Of California | Prokineticin receptor antagonists and uses thereof |
| EP2375899B1 (en) | 2009-01-12 | 2015-02-25 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof in the treatment of diabetes |
| GB201209587D0 (en) * | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| JP6343541B2 (ja) | 2014-10-09 | 2018-06-13 | 株式会社ケーヒン・サーマル・テクノロジー | エバポレータおよびこれを用いた車両用空調装置 |
| GB201420095D0 (en) * | 2014-11-12 | 2014-12-24 | Takeda Pharmaceutical | New use |
-
2014
- 2014-06-20 AU AU2014282977A patent/AU2014282977B2/en active Active
- 2014-06-20 WO PCT/GB2014/051900 patent/WO2014202999A1/en active Application Filing
- 2014-06-20 US US14/893,148 patent/US10208016B2/en active Active
- 2014-06-20 CA CA2914263A patent/CA2914263C/en active Active
- 2014-06-20 EA EA201600032A patent/EA029430B1/ru not_active IP Right Cessation
- 2014-06-20 JP JP2016520745A patent/JP6401254B2/ja active Active
- 2014-06-20 EP EP14732622.7A patent/EP3010900B1/en active Active
- 2014-06-20 CN CN201480035202.8A patent/CN105324372B/zh active Active
-
2016
- 2016-06-17 HK HK16107004.1A patent/HK1219722A1/zh unknown
-
2018
- 2018-05-04 US US15/971,330 patent/US10308635B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2914263C (en) | 2021-05-18 |
| US10308635B2 (en) | 2019-06-04 |
| JP6401254B2 (ja) | 2018-10-10 |
| CN105324372A (zh) | 2016-02-10 |
| US20180251445A1 (en) | 2018-09-06 |
| EP3010900A1 (en) | 2016-04-27 |
| AU2014282977B2 (en) | 2018-06-14 |
| US10208016B2 (en) | 2019-02-19 |
| CN105324372B (zh) | 2018-03-06 |
| US20160122317A1 (en) | 2016-05-05 |
| EP3010900B1 (en) | 2018-01-03 |
| CA2914263A1 (en) | 2014-12-24 |
| EA201600032A1 (ru) | 2016-08-31 |
| WO2014202999A1 (en) | 2014-12-24 |
| JP2016522244A (ja) | 2016-07-28 |
| AU2014282977A1 (en) | 2015-12-24 |
| BR112015031827A2 (pt) | 2017-07-25 |
| EA029430B1 (ru) | 2018-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279572A (en) | Preparations for the modulation of tau expression | |
| HRP20180817T1 (hr) | Sastavi i postupci za modulaciju farnesoid-x-receptora | |
| IL244759A0 (en) | Preparations for modulation of c9orf72 expression | |
| EP2850182A4 (en) | COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF ATP2A2 | |
| EP3033425A4 (en) | Compositions and methods for modulating expression of frataxin | |
| HRP20181596T1 (hr) | Tiazolopirimidinoni kao modulatori aktivnosti nmda receptora | |
| HK1217489A1 (zh) | 調節劑 | |
| IL246299A0 (en) | History of Sorbibin and preparations containing them | |
| HK1218542A1 (zh) | 調節劑 | |
| EP3014628B8 (en) | Process of generating germanium-68 | |
| HK1223018A1 (zh) | 類胡蘿蔔素的醫藥組合物 | |
| ZA201508677B (en) | Stabilized mesembrine compositions | |
| HK1219722A1 (zh) | -磺酰基派啶衍生物作為前動力蛋白受體的調節劑 | |
| HK1219723A1 (zh) | 作為前動力蛋白受體調節劑的派啶和氮雜䓬衍生物 | |
| HK1211855A1 (zh) | 調節 穩定性的方法 | |
| EP3006054A4 (en) | Material for regeneration of periodontal tissue | |
| TWM475191U (en) | Structural improvement of hinge | |
| AU2013904208A0 (en) | Packaging for Worms | |
| GB201300958D0 (en) | Parameter application |